A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults

NCT02420444 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: BCG SSI
BIOLOGICAL: Placebo
BIOLOGICAL: AERAS-404

Sponsor

Aeras

Collaborators

[object Object]